SCHEMBL28912802

SCHEMBL28912802

CC1Cn2ncc(O)c2CN1C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ ATR Q13535 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21058321 1.00 MAPT (0.34) MAPTGAATSHRATR
SCHEMBL21958284 0.86 MAPT (0.32) MAPTGAA
SCHEMBL28562895 0.86 MAPT (0.32) MAPTGAA
SCHEMBL21986932 0.86 MAPT (0.32) MAPTGAA
SCHEMBL17925845 0.86 MAPT (0.32) MAPTGAA
SCHEMBL21058323 0.86 MAPT (0.32) MAPTGAA
SCHEMBL21058306 0.84 TSHR (0.33) MAPTTSHR
SCHEMBL19632326 0.82 GPR119 (0.38) —
SCHEMBL21058315 0.82 GPR119 (0.38) —
SCHEMBL21058304 0.81 MAPT (0.31) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153682-B Novel pyrazine compounds with oxygen, sulfur and nitrogen linkers for the treatment of infectious diseases 豪夫迈·罗氏有限公司 2021-05-25 — — CN disclosed
Send feedback